- Home
- NERV vs INBS Comparison
NERV vs INBS Comparison
Compare NERV & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- INBS
- Stock Information
- Founded
- NERV 2007
- INBS 2016
- Country
- NERV United States
- INBS United States
- Employees
- NERV N/A
- INBS N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- INBS Medical Specialities
- Sector
- NERV Health Care
- INBS Health Care
- Exchange
- NERV Nasdaq
- INBS Nasdaq
- Market Cap
- NERV 12.0M
- INBS 11.7M
- IPO Year
- NERV 2014
- INBS N/A
- Fundamental
- Price
- NERV $2.25
- INBS $1.47
- Analyst Decision
- NERV Hold
- INBS
- Analyst Count
- NERV 1
- INBS 0
- Target Price
- NERV $5.00
- INBS N/A
- AVG Volume (30 Days)
- NERV 35.1K
- INBS 188.5K
- Earning Date
- NERV 08-14-2025
- INBS 08-15-2025
- Dividend Yield
- NERV N/A
- INBS N/A
- EPS Growth
- NERV N/A
- INBS N/A
- EPS
- NERV 1.48
- INBS N/A
- Revenue
- NERV N/A
- INBS $3,052,532.00
- Revenue This Year
- NERV N/A
- INBS $280.88
- Revenue Next Year
- NERV N/A
- INBS $126.26
- P/E Ratio
- NERV $1.52
- INBS N/A
- Revenue Growth
- NERV N/A
- INBS N/A
- 52 Week Low
- NERV $1.15
- INBS $1.00
- 52 Week High
- NERV $3.00
- INBS $3.00
- Technical
- Relative Strength Index (RSI)
- NERV 69.92
- INBS 41.02
- Support Level
- NERV $1.79
- INBS $1.42
- Resistance Level
- NERV $1.81
- INBS $1.53
- Average True Range (ATR)
- NERV 0.10
- INBS 0.09
- MACD
- NERV 0.01
- INBS -0.01
- Stochastic Oscillator
- NERV 76.56
- INBS 25.00
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).